{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:45:09Z","timestamp":1759160709665,"version":"3.44.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01762-x","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:23:06Z","timestamp":1746170586000},"page":"3877-3888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational Drug Repurposing Screening Targeting Profibrotic Cytokine in Acute Respiratory Distress Syndrome"],"prefix":"10.1007","volume":"83","author":[{"given":"Yong","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"1762_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/biomedicines12030639","volume":"12","author":"M Lazar","year":"2024","unstructured":"Lazar, M., Sandulescu, M., Barbu, E. C., Chitu-Tisu, C. E., Andreescu, D. I., Anton, A. N., Erculescu, T. M., Petre, A. M., Duca, G. T., Simion, V., Padiu, I. F., Pacurar, C. G., Rosca, R., Simian, T. M., Oprea, C. A., & Ion, D. A. (2024). The role of cytokines and molecular pathways in lung fibrosis following SARS-CoV-2 infection: A physiopathologic (re)view. Biomedicines, 12, 639.","journal-title":"Biomedicines"},{"key":"1762_CR2","volume":"133","author":"MA Ghonim","year":"2023","unstructured":"Ghonim, M. A., Boyd, D. F., Flerlage, T., & Thomas, P. G. (2023). Pulmonary inflammation and fibroblast immunoregulation: From bench to bedside. JCI Insight, 133, e170499.","journal-title":"JCI Insight"},{"key":"1762_CR3","doi-asserted-by":"publisher","first-page":"e0206105","DOI":"10.1371\/journal.pone.0206105","volume":"13","author":"JM Forel","year":"2018","unstructured":"Forel, J. M., Guervilly, C., Farnarier, C., Donati, S. Y., Hraiech, S., Persico, N., Allardet-Servent, J., Coiffard, B., Gainnier, M., Loundou, A., Sylvestre, A., Roch, A., Bourenne, J., & Papazian, L. (2018). Transforming growth factor-\u03b21 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome. PLoS ONE, 13, e0206105.","journal-title":"PLoS ONE"},{"key":"1762_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024). TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduction and Targeted Therapy, 9, 61.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1762_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1513\/pats.200601-008AW","volume":"3","author":"D Sheppard","year":"2006","unstructured":"Sheppard, D. (2006). Transforming growth factor beta: A central modulator of pulmonary and airway inflammation and fibrosis. Proceedings of the American Thoracic Society, 3, 413\u2013417.","journal-title":"Proceedings of the American Thoracic Society"},{"key":"1762_CR6","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis, N. (2020). Transforming growth factor-\u03b2 in tissue fibrosis. Journal of Experimental Medicine, 217, e20190103.","journal-title":"Journal of Experimental Medicine"},{"key":"1762_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/ALN.0000000000000264","volume":"121","author":"NE Cabrera-Benitez","year":"2014","unstructured":"Cabrera-Benitez, N. E., Laffey, J. G., Parotto, M., Spieth, P. M., Villar, J., Zhang, H., & Slutsky, A. S. (2014). Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: A significant contributor to poor outcome. Anesthesiology, 121, 189\u2013198.","journal-title":"Anesthesiology"},{"key":"1762_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02678-5","volume":"25","author":"Q Huang","year":"2024","unstructured":"Huang, Q., Le, Y., Li, S., & Bian, Y. (2024). Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). Respiratory Research, 25, 30.","journal-title":"Respiratory Research"},{"key":"1762_CR9","doi-asserted-by":"publisher","first-page":"1054690","DOI":"10.3389\/fcvm.2022.1054690","volume":"9","author":"LM Arguinchona","year":"2023","unstructured":"Arguinchona, L. M., Zagona-Prizio, C., Joyce, M. E., Chan, E. D., & Maloney, J. P. (2023). Microvascular significance of TGF-\u03b2 axis activation in COVID-19. Frontiers in Cardiovascular Medicine, 9, 1054690.","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"1762_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/biom11020310","volume":"11","author":"M Sisto","year":"2021","unstructured":"Sisto, M., Ribatti, D., & Lisi, S. (2021). Organ fibrosis and autoimmunity: The role of inflammation in TGF\u03b2-dependent EMT. Biomolecules, 11, 310.","journal-title":"Biomolecules"},{"key":"1762_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2021.09.001","volume":"241","author":"JE Michalski","year":"2022","unstructured":"Michalski, J. E., Kurche, J. S., & Schwartz, D. A. (2022). From ARDS to pulmonary fibrosis: The next phase of the COVID-19 pandemic? Translational Research, 241, 13\u201324.","journal-title":"Translational Research"},{"key":"1762_CR12","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3390\/biom10121666","volume":"10","author":"X Shi","year":"2020","unstructured":"Shi, X., Young, C. D., Zhou, H., & Wang, X. (2020). Transforming growth factor-\u03b2 signaling in fibrotic diseases and cancer-associated fibroblasts. Biomolecules, 10, 1666.","journal-title":"Biomolecules"},{"key":"1762_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022301","volume":"9","author":"RJ Akhurst","year":"2017","unstructured":"Akhurst, R. J. (2017). Targeting TGF-\u03b2 signaling for therapeutic gain. Cold Spring Harbor Perspectives in Biology, 9, a022301.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"1762_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022293","volume":"10","author":"KK Kim","year":"2018","unstructured":"Kim, K. K., Sheppard, D., & Chapman, H. A. (2018). TGF-\u03b21 signaling and tissue fibrosis. Cold Spring Harbor Perspectives in Biology, 10, a022293.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"1762_CR15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31756","volume":"7","author":"A Ramachandran","year":"2018","unstructured":"Ramachandran, A., Viz\u00e1n, P., Das, D., Chakravarty, P., Vogt, J., Rogers, K. W., M\u00fcller, P., Hinck, A. P., Sapkota, G. P., & Hill, C. S. (2018). TGF-\u03b2 uses a novel mode of receptor activation to phosphorylate SMAD1\/5 and induce epithelial-to-mesenchymal transition. eLife, 7, e31756.","journal-title":"eLife"},{"key":"1762_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","volume":"85","author":"KC Flanders","year":"2004","unstructured":"Flanders, K. C. (2004). Smad3 as a mediator of the fibrotic response. International Journal of Experimental Pathology, 85, 47\u201364.","journal-title":"International Journal of Experimental Pathology"},{"key":"1762_CR17","doi-asserted-by":"publisher","first-page":"107256","DOI":"10.1016\/j.jbc.2024.107256","volume":"300","author":"K Miyazawa","year":"2024","unstructured":"Miyazawa, K., Itoh, Y., Fu, H., & Miyazono, K. (2024). Receptor-activated transcription factors and beyond: multiple modes of Smad2\/3-dependent transmission of TGF-\u03b2 signaling. Journal of Biological Chemistry, 300, 107256.","journal-title":"Journal of Biological Chemistry"},{"key":"1762_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fphar.2017.00461","volume":"8","author":"KL Walton","year":"2017","unstructured":"Walton, K. L., Johnson, K. E., & Harrison, C. A. (2017). Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis. Frontiers in Pharmacology, 8, 461.","journal-title":"Frontiers in Pharmacology"},{"key":"1762_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/biom12030373","volume":"12","author":"HL Wang","year":"2022","unstructured":"Wang, H. L., Wang, L., Zhao, C. Y., & Lan, H. Y. (2022). Role of TGF-beta signaling in beta cell proliferation and function in diabetes. Biomolecules, 12, 373.","journal-title":"Biomolecules"},{"key":"1762_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng, D., Fu, M., Wang, M., Wei, Y., & Wei, X. (2022). Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Molecular Cancer, 21, 104.","journal-title":"Molecular Cancer"},{"key":"1762_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","volume":"14","author":"BG Kim","year":"2021","unstructured":"Kim, B. G., Malek, E., Choi, S. H., Ignatz-Hoover, J. J., & Driscoll, J. J. (2021). Novel therapies emerging in oncology to target the TGF-\u03b2 pathway. Journal of Hematology and Oncology, 14, 55.","journal-title":"Journal of Hematology and Oncology"},{"key":"1762_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0356-4","volume":"6","author":"RB Holmgaard","year":"2018","unstructured":"Holmgaard, R. B., Schaer, D. A., Li, Y., Castaneda, S. P., Murphy, M. Y., Xu, X., Inigo, I., Dobkin, J., Manro, J. R., Iversen, P. W., Surguladze, D., Hall, G. E., Novosiadly, R. D., Benhadji, K. A., Plowman, G. D., Kalos, M., & Driscoll, K. E. (2018). Targeting the TGF\u03b2 pathway with galunisertib, a TGF\u03b2RI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade. Journal for Immunotherapy of Cancer, 6, 47.","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"1762_CR23","doi-asserted-by":"crossref","unstructured":"Choi, S. H., Myers, J., Tomchuck, S., Bonner, M., Eid, S., Kingsley, D., VanHeyst, K., Kim, S. J., Kim, B. G., & Huang, A. Y. (2023). Oral TGF-\u03b2R1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Research Square. Preprint retrieved from rs.3.rs-2709282. https:\/\/pubmed.ncbi.nlm.nih.gov\/37066414\/.","DOI":"10.21203\/rs.3.rs-2709282\/v1"},{"key":"1762_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/CCO.0b013e3282f0ad0e","volume":"19","author":"M Pennison","year":"2007","unstructured":"Pennison, M., & Pasche, B. (2007). Targeting transforming growth factor-beta signaling. Current Opinion in Oncology, 19, 579\u2013585.","journal-title":"Current Opinion in Oncology"},{"key":"1762_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43556-022-00109-9","volume":"3","author":"Y Tie","year":"2022","unstructured":"Tie, Y., Tang, F., Peng, D., Zhang, Y., & Shi, H. (2022). TGF-beta signal transduction: Biology, function and therapy for diseases. Molecular Biomedicine, 3, 45.","journal-title":"Molecular Biomedicine"},{"key":"1762_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/cancers13030379","volume":"13","author":"V G\u00f3mez-Gil","year":"2021","unstructured":"G\u00f3mez-Gil, V. (2021). Therapeutic implications of TGF\u03b2 in cancer treatment: A systematic review. Cancers, 13, 379.","journal-title":"Cancers"},{"key":"1762_CR27","unstructured":"Tie, Y., Tang, F., & Peng, D., et al. (2022). TGF-beta signal transduction: A pharmacological target in the pathogenesis and therapeutics of fibrosis and cancer. Pharmacological Research, 175, 104558."},{"key":"1762_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59893-5","volume":"10","author":"E Hong","year":"2020","unstructured":"Hong, E., Park, S., Ooshima, A., Hong, C. P., Park, J., Heo, J. S., Lee, S., An, H., Kang, J. M., Park, S. H., Park, J. O., & Kim, S. J. (2020). Inhibition of TGF-\u03b2 signaling in combination with nal-IRI plus 5-Fluorouracil\/Leucovorin suppresses invasion and prolongs survival in pancreatic tumor mouse models. Scientific Reports, 10, 2935.","journal-title":"Scientific Reports"},{"key":"1762_CR29","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000056","volume":"10","author":"RK Kelley","year":"2019","unstructured":"Kelley, R. K., Gane, E., Assenat, E., Siebler, J., Galle, P. R., Merle, P., Hourmand, I. O., Cleverly, A., Zhao, Y., Gueorguieva, I., Lahn, M., Faivre, S., Benhadji, K. A., & Giannelli, G. (2019). A phase 2 study of galunisertib (TGF-\u03b21 receptor type I inhibitor) and sorafenib in patients with advanced hepatocellular carcinoma. Clinical and Translational Gastroenterology, 10, e00056.","journal-title":"Clinical and Translational Gastroenterology"},{"key":"1762_CR30","doi-asserted-by":"crossref","unstructured":"Malek, E., Rana, P. S., Swamydas, M., Daunov, M., Miyagi, M., Murphy, E., Ignatz-Hoover, J. J., Metheny, L., Seong Jin, K., & Driscoll, J. J. (2023). Vactosertib, a novel TGF-\u03b21 type I receptor kinase inhibitor, improves T-cell fitness: A single-arm, phase 1b trial in relapsed\/refractory multiple myeloma. Research Square. Preprint retrieved from rs.3.rs-3112163. https:\/\/pubmed.ncbi.nlm.nih.gov\/37503043\/.","DOI":"10.21203\/rs.3.rs-3112163\/v1"},{"key":"1762_CR31","doi-asserted-by":"publisher","first-page":"0288208","DOI":"10.1371\/journal.pone.0288208","volume":"18","author":"R Reza","year":"2023","unstructured":"Reza, R., Morshed, N., Samdani, M. N., & Reza, M. S. (2023). Pharmacophore mapping approach to find anti-cancer phytochemicals with metformin-like activities against transforming growth factor (TGF)-beta receptor I kinase: An in silico study. PLoS ONE, 18, 0288208.","journal-title":"PLoS ONE"},{"key":"1762_CR32","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., Gable, A. L., Fang, T., Doncheva, N. T., Pyysalo, S., Bork, P., Jensen, L. J., & von Mering, C. (2023). The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research, 51, D638\u2013D646.","journal-title":"Nucleic Acids Research"},{"key":"1762_CR33","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/ijms23020811","volume":"23","author":"ME Bragina","year":"2022","unstructured":"Bragina, M. E., Daina, A., Perez, M. A. S., Michielin, O., & Zoete, V. (2022). SwissSimilarity 2021 web tool: Novel chemical libraries and additional methods for an enhanced ligand-based virtual screening experience. International Journal of Molecular Sciences, 23, 811.","journal-title":"International Journal of Molecular Sciences"},{"key":"1762_CR34","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox, C., Wilson, M., Klinger, C. M., Franklin, M., Oler, E., Wilson, A., Pon, A., Cox, J., Chin, N., Strawbridge, S. A., Garcia-Patino, M., Kruger, R., Sivakumaran, A., Sanford, S., Doshi, R., Khetarpal, N., Fatokun, O., Doucet, D., Zubkowski, A., Rayat, D. Y., Jackson, H., Harford, K., Anjum, A., Zakir, M., Wang, F., Tian, S., Lee, B., Liigand, J., Peters, H., Wang, R., Nguyen, T., So, D., Sharp, M., da Silva, R., Gabriel, C., Scantlebury, J., Jasinski, M., Ackerman, D., Jewison, T., Sajed, T., Gautam, V., & Wishart, D. S. (2024). DrugBank 6.0: The DrugBank knowledgebase for 2024. Nucleic Acids Research, 52, D1265\u2013D1275.","journal-title":"Nucleic Acids Research"},{"key":"1762_CR35","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., & Overington, J. P. (2012). ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Research, 40, D1100\u2013D1107.","journal-title":"Nucleic Acids Research"},{"key":"1762_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 1263, 243\u2013250.","journal-title":"Methods in Molecular Biology"},{"key":"1762_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF chimera\u2014A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25, 1605\u20131612.","journal-title":"Journal of Computational Chemistry"},{"key":"1762_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717.","journal-title":"Scientific Reports"},{"key":"1762_CR39","doi-asserted-by":"publisher","first-page":"109094","DOI":"10.1016\/j.isci.2024.109094","volume":"27","author":"G Du","year":"2024","unstructured":"Du, G., Chen, J., Zhu, X., & Zhu, Z. (2024). Bioinformatics analysis identifies TGF-\u03b2 signaling pathway-associated molecular subtypes and gene signature in diabetic foot. iScience, 27, 109094.","journal-title":"iScience"},{"key":"1762_CR40","doi-asserted-by":"publisher","first-page":"1113061","DOI":"10.3389\/fmolb.2023.1113061","volume":"10","author":"PY Chen","year":"2023","unstructured":"Chen, P. Y., Qin, L., & Simons, M. (2023). TGF\u03b2 signaling pathways in human health and disease. Frontiers in Molecular Biosciences, 10, 1113061.","journal-title":"Frontiers in Molecular Biosciences"},{"key":"1762_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/ijmm.2021.4888","volume":"47","author":"J Wang","year":"2021","unstructured":"Wang, J., Xiang, H., Lu, Y., & Wu, T. (2021). Role and clinical significance of TGF-\u03b21 and TGF-\u03b2R1 in malignant tumors (Review). International Journal of Molecular Medicine, 47, 55.","journal-title":"International Journal of Molecular Medicine"},{"key":"1762_CR42","first-page":"4479","volume":"9","author":"S Herbertz","year":"2015","unstructured":"Herbertz, S., Sawyer, J. S., Stauber, A. J., Gueorguieva, I., Driscoll, K. E., Estrem, S. T., Cleverly, A. L., Desaiah, D., Guba, S. C., Benhadji, K. A., Slapak, C. A., & Lahn, M. M. (2015). Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Design, Development and Therapy, 9, 4479\u20134499.","journal-title":"Drug Design, Development and Therapy"},{"key":"1762_CR43","doi-asserted-by":"publisher","first-page":"114716","DOI":"10.1016\/j.biopha.2023.114716","volume":"162","author":"JE Lee","year":"2023","unstructured":"Lee, J. E., Lee, P., Yoon, Y. C., Han, B. S., Ko, S., Park, M. S., Lee, Y. J., Kim, S. E., Cho, Y. J., Lim, J. H., Ryu, J. K., Shim, S., Kim, D. K., Jung, K. H., & Hong, S. S. (2023). Vactosertib, TGF-\u03b2 receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer. Biomedicine and Pharmacotherapy, 162, 114716.","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"1762_CR44","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022277","volume":"9","author":"J Seoane","year":"2017","unstructured":"Seoane, J., & Gomis, R. R. (2017). TGF-\u03b2 family signaling in tumor suppression and cancer progression. Cold Spring Harbor Perspectives in Biology, 9, a022277.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"1762_CR45","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn, T. A., & Ramalingam, T. R. (2012). Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nature Medicine, 18, 1028\u20131040.","journal-title":"Nature Medicine"},{"key":"1762_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12026-022-09267-y","volume":"70","author":"N Shi","year":"2022","unstructured":"Shi, N., Wang, Z., Zhu, H., Liu, W., Zhao, M., Jiang, X., Zhao, J., Ren, C., Zhang, Y., & Luo, L. (2022). Research progress on drugs targeting the TGF-\u03b2 signaling pathway in fibrotic diseases. Immunologic Research, 70, 276\u2013288.","journal-title":"Immunologic Research"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01762-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:58:43Z","timestamp":1757203123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01762-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01762-x","relation":{},"ISSN":["1559-0283"],"issn-type":[{"type":"electronic","value":"1559-0283"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"17 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}